A new dendritic cell vaccine generated with interleukin-3 and interferon-beta induces CD8+ T cell responses against NA17-A2 tumor peptide in melanoma patients.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples